[Federal Register Volume 86, Number 222 (Monday, November 22, 2021)]
[Notices]
[Pages 66321-66322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-25413]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request; Federal COVID 
Response--Audience Feedback To Inform Ongoing Messaging and Strategies 
for ``Combat COVID''

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the 
National Institutes of Health (NIH) has submitted to the Office of 
Management and Budget (OMB) a request for review and approval of the 
information collection listed below.

DATES: Comments regarding this information collection are best assured 
of having their full effect if received within 30-days of the date of 
this publication.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the data collection plans and 
instruments, contact: Ms. Mikia P. Currie, Office of Policy for 
Extramural Research Administration, 6705 Rockledge Drive, Suite 350, 
Bethesda, Maryland 20892, or call a non-toll-free number (301) 435-0941 
or Email your request, including your address to: 
[email protected].

SUPPLEMENTARY INFORMATION: This proposed information collection was 
previously published in the Federal Register on September 7, 2021, page 
50143 (86 FR 50143) and allowed 60 days for public comment. No public 
comments were received. The purpose of this notice is to allow an 
additional 30 days for public comment. The National Institutes of 
Health may not conduct or sponsor, and the respondent is not required 
to respond to, any information collection that has been extended, 
revised, or implemented on or after October 1, 1995, unless it displays 
a currently valid OMB control number.
    In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction 
Act of 1995, the National Institutes of Health (NIH) has submitted to 
the Office of Management and Budget (OMB) a request for review and 
approval of the information collection listed below.
    Proposed Collection: Audience Feedback to Inform Ongoing Messaging 
and Strategies for ``Combat COVID,'' OMB #0925-0769, exp., date 12/31/
2021, EXTENSION National Institutes of Health (NIH).
    Need and Use of Information Collection: The purpose of the 
information collection is to collect routine feedback from the Combat 
COVID Initiative's two target audiences (the general public and 
healthcare providers) to identify evolving needs and better disseminate 
relevant information as it relates to COVID-19 treatment and 
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) 
clinical trial resources, specifically. Data collected will be used to 
inform the development and broad dissemination of Combat COVID 
resources, including new or enhanced message and material concepts 
(e.g., social media ads, digital display ads, out-of-home ads), and/or 
web pages (combatcovid.hhs.gov). Because the COVID-19 treatment 
landscape continues to evolve, new evidence-based information continues 
to come to the forefront, and audience needs continue to change, it is 
critical for the Federal COVID Response (FCR) Team to collect quick 
audience feedback from the general public (especially from groups who 
have not historically been well-represented in clinical trials) and 
healthcare providers to identify these evolving needs. By understanding 
target audience needs, the FCR team will be able to properly develop 
and broadly disseminate relevant COVID-19 treatment and ACTIV clinical 
trial resources. A change request was recently submitted to update the 
recall stimuli (still images, audio, and video or animated images) for 
questions about exposure to the Combat COVID message and materials. It 
also removed questions that are no longer relevant and replaced them 
with more relevant questions about the latest COVID-19 treatment 
options and clinical trials.
    OMB approval is requested for 1 year. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 3,528.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
                    Form name                        Number of     responses per   per response    Total annual
                                                    respondents     respondent      (in hours)     burden hours
----------------------------------------------------------------------------------------------------------------
Consumer Audience Feedback Team Screener........             120               1            5/60              10
HCP Audience Feedback Team Screener.............              40               1            5/60               3
Consumer Audience Feedback Activity.............              60               8               1             480
HCP Audience Feedback Activity..................              20               8               1             160

[[Page 66322]]

 
Benchmark & Follow-Up Web Surveys--Consumer                2,000               5           15/60           2,500
 Audience.......................................
Benchmark & Follow-Up Web Survey--HCP Audience..             300               5           15/60             375
                                                 ---------------------------------------------------------------
    Total.......................................           2,540          12,300  ..............           3,528
----------------------------------------------------------------------------------------------------------------


    Dated: November 16, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-25413 Filed 11-19-21; 8:45 am]
BILLING CODE 4140-01-P